The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Sudhir Sethi, the main promoter of Beryl Drugs Ltd, has disclosed an acquisition of 11,786 equity shares (0.23%) through open market transactions on 10-03-2026 under SEBI SAST Regulation 29(2). His stake in the company has increased from 8.65% (4,38,504 shares) to 8.88% (4,50,290 shares). The total equity share capital of the company remains at 50,71,700 shares. The promoter continues to hold less than 10% of the company after this small incremental purchase.
This is a minor insider buy by the promoter, signalling modest confidence but no major change in ownership structure. Given the small size (0.23%), the impact on share price or shareholder perception is likely negligible.